Welcome
Canadian Hematology Consensus Group
Developing evidence-based guidance in the management of lymphoid malignancies is essential for formulating effective hematology recommendations.
Developing evidence-based guidance in the management of lymphoid malignancies is essential for formulating effective hematology recommendations.
The Canadian Hematology Consensus Group (CHCG) is an independent collaboration of Canadian hematologists, nurses, pharmacists, and medical communications professionals dedicated to improving patient care through the development of national hematology recommendations.
The Scientific Committee, chaired by leading experts in hematology, provides evidence-based guidance on the management of hematological malignancies, including lymphoid malignancies. Consensus papers are endorsed by the Canadian Hematology Society (CHS), ensuring that these recommendations reflect the collective expertise of Canada's hematology community.
IMPACT Medicom Inc. supports the process through project management, editorial services, and meeting coordination. While the Program Office provides logistical and editorial support, all scientific content and recommendations are developed and approved by the Scientific Committee.
Our goal is to produce timely, high-quality, evidence-based recommendations that support best practices in the treatment of hematological malignancies in Canada.
Canadian Consensus Group
Copyright © 2026 Canadian Consensus Group - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.